Search Within

Mark Kris

  1. "PLos Medicine"
Formats
  1. Journal Article (2)
Groups
  1. Department of Medicine (2)
  2. Department of Pathology and Laboratory Medicine (2)
  3. Solid Tumor Oncology Division (2)
  4. Thoracic Oncology (2)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)

More Groups

People
  1. Gregory Riely (2)
  2. Harold Varmus (2)
  3. Maureen Zakowski (2)
  4. Vincent Miller (2)
  5. William Pao (2)
  6. Katerina Politi (1)

More People

Years
  1. 2005 (2)
Publications
  1. PLos Medicine (2)
Publishers
  1. Public Library of Science (2)

Results (2)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    Journal Article

    Pao, W.; Wang, T. Y.; Riely, G. J.; Miller, V. A.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.; Heelan, R. T.; Kris, M. G.; Varmus, H. E.
    PLos Medicine (2005)

    Fulltext@MSK | Save
  • Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    Journal Article

    Pao, W.; Miller, V. A.; Politi, K. A.; Riely, G. J.; Somwar, R.; Zakowski, M. F.; Kris, M. G.; Varmus, H.
    PLos Medicine (2005)

    Fulltext@MSK | Save